Antiviral Susceptibility of Influenza A(H5N1) Clade 2.3.2.1c and 2.3.4.4b Viruses from Humans, 2023–2024
Emerging Infectious Diseases · 2025-04 · 31 (4)
DOI: 10.3201/eid3104.241820 ↗Kurz gefasst
Fachartikel in der Zeitschrift Emerging Infectious Diseases, 2025-04. Verfasst von Philippe Noriel Q Pascua und 13 weiteren Autor:innen. Hauptthemen laut MEDLINE: Antiviral Agents, Influenza A Virus, H5N1 Subtype, Influenza, Human. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Zitieren
APA
Pascua, P. N. Q., Chesnokov, A., Nguyen, H. T., Di, H., La Cruz, J., Jang, Y., Ivashchenko, A. A., Ivachtchenko, A. V., Karlsson, E. A., Sar, B., Savuth, C., Uyeki, T. M., Davis, C. T., & Gubareva, L. V. (2025). Antiviral Susceptibility of Influenza A(H5N1) Clade 2.3.2.1c and 2.3.4.4b Viruses from Humans, 2023–2024. Emerging Infectious Diseases, 31(4). https://doi.org/10.3201/eid3104.241820
Vancouver
Pascua PNQ, Chesnokov A, Nguyen HT, Di H, La Cruz J, Jang Y, et al. Antiviral Susceptibility of Influenza A(H5N1) Clade 2.3.2.1c and 2.3.4.4b Viruses from Humans, 2023–2024. Emerging Infectious Diseases. 2025;31(4). doi:10.3201/eid3104.241820
BibTeX
@article{Pascua2025,
author = {Pascua, Philippe Noriel Q and Chesnokov, Anton and Nguyen, Ha T and Di, Han and La Cruz, Juan De and Jang, Yunho and Ivashchenko, Andrei A and Ivachtchenko, Alexandre V and Karlsson, Erik A and Sar, Borann and Savuth, Chin and Uyeki, Timothy M and Davis, Charles Todd and Gubareva, Larisa V},
title = {Antiviral Susceptibility of Influenza A(H5N1) Clade 2.3.2.1c and 2.3.4.4b Viruses from Humans, 2023–2024},
journal = {Emerging Infectious Diseases},
year = {2025},
volume = {31},
number = {4},
doi = {10.3201/eid3104.241820}
}
EUVIMED